A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC by Camidge, D. Ross, MD, PhD, Barlesi, Fabrice, MD, PhD, Goldman, Jonathan W., MD, Morgensztern, Daniel, MD, Heist, Rebecca, MD, MPH, Vokes, Everett, MD, Angevin, Eric, MD, PhD, Hong, David S., MD, Rybkin, Igor I., MD, Barve, Minal, MD, Bauer, Todd M., MD, Delmonte, Angelo, MD, Dunbar, Martin, DrPH, Motwani, Monica, PhD, Parikh, Apurvasena, PhD, Noon, Elysa, PhD, Wu, Jun, MD, Blot, Vincent, PhD, Kelly, Karen, MD

Get full text